Distribution of resveratrol metabolites in liver, adipose tissue, and skeletal muscle in rats fed different doses of this polyphenol

Journal of Agricultural and Food Chemistry

Volumn 60, Issue 19, 2012, Pages 4833-4840

  Andres Lacueva, Cristina ^a,b   MacArulla, M Teresa ^c   Rotches Ribalta, Maria ^a,b   Boto Ordóñez, María ^a,d   Urpi Sarda, Mireia ^d   Rodríguez, Víctor M ^c   Portillo, María P ^c  

^a UNIVERSITY OF BARCELONA   (Spain)

^b Ministry of Science and Innovation   (Spain)

^c INSTITUTO DE SALUD CARLOS III   (Spain)

^d Instituto de Salud Carlos III   (Spain)

Author keywords

adipose tissue; dihydroresveratrol; glucuronide metabolites; liver; resveratrol; skeletal muscle; sulfate metabolites

Indexed keywords

ADIPOSE TISSUE; DIHYDRORESVERATROL; GLUCURONIDES; RESVERATROL; SKELETAL MUSCLE;

LIQUID CHROMATOGRAPHY; LIVER; MASS SPECTROMETRY; METABOLITES; MUSCLE; RATS; SULFUR COMPOUNDS;

BIOMOLECULES;

POLYPHENOL; RESVERATROL; STILBENE DERIVATIVE;

ADIPOSE TISSUE; ANIMAL; ARTICLE; CHEMISTRY; HUMAN; LIVER; MALE; METABOLISM; METAGENOME; MICROBIOLOGY; RAT; SKELETAL MUSCLE; SPRAGUE DAWLEY RAT;

ADIPOSE TISSUE; ANIMALS; HUMANS; LIVER; MALE; METAGENOME; MUSCLE, SKELETAL; POLYPHENOLS; RATS; RATS, SPRAGUE-DAWLEY; STILBENES;

RATTUS;

EID: 84861142927     PISSN: 00218561     EISSN: 15205118     Source Type: Journal    
DOI: 10.1021/jf3001108     Document Type: Article

References (48)

1. Signorelli, P.; Ghidoni, R. Resveratrol as an anticancer nutrient: Molecular basis, open questions and promises J. Nutr. Biochem. 2005, 16, 449-466
2. Frémont, L. Biological effects of resveratrol Life Sci. 2000, 66, 663-673
3. Soleas, G. J.; Angelini, M.; Grass, L.; Diamendis, E. P.; Goldberg, D. M. Absorption of trans -resveratrol in rats Methods Enzymol. 2001, 335, 145-154
4. Walle, T. Biovailability of resveratrol Ann. N.Y. Acad. Sci. 2011, 1215, 9-15
5. Maier-Salamon, A.; Hagenauer, B.; Reznicek, G.; Szekeres, T.; Thalhammer, T.; Jäger, W. Metabolism and disposition of resveratrol in the isolated perfused rat liver: Role of Mrp2 in the biliary excretion of glucuronides J. Pharm. Sci. 2008, 97, 1615-1628
6. Wenzel, E.; Somoza, V. Metabolism and bioavailability of trans -resveratrol Mol. Nutr. Food Res. 2005, 49, 472-481
7. Andrés-Lacueva, C.; Urpí-Sardá, M.; Zamora-Ros, R.; Lamuela-Raventós, R. M. Bioavailability and metabolism of resveratrol. In Plant Phenolics and Human Health: Biochemistry, Nutrition and Pharmacology; Fraga, C. G., Ed.; John Wiley & Sons, Inc.: Hoboken, NJ, 2009; pp 265-299.
8. Boocock, D. J.; Faust, G. E.; Patel, K. R.; Schinas, A. M.; Brown, V. A.; Ducharme, M. P.; Booth, T. D.; Crowell, J. A.; Perloff, M.; Gescher, A. J.; Steward, W. P.; Brenner, D. E. Phase I dose escalation pharmacokinetic study in healthy volunteers of resveratrol, a potential cancer chemopreventive agent Cancer Epidemiol. Biomarkers Prev. 2007, 16, 1246-1252
9. Jang, M.; Cai, L.; Udeani, G. O.; Slowing, K. V.; Thomas, C. F.; Beecher, C. W.; Fong, H. H.; Farnsworth, N. R.; Kinghorn, A. D.; Mehta, R. G.; Moon, R. C.; Pezzuto, J. M. Cancer chemopreventive activity of resveratrol, a natural product derived from grapes Science 1997, 275, 218-220
10. Weng, C. J.; Wu, C. F.; Huang, H. W.; Wu, C. H.; Ho, C. T.; Yen, G. C. Evaluation of anti-invasion effect of resveratrol and related methoxy analogues on human hepatocarcinoma cells J. Agric. Food Chem. 2010, 58, 2886-2894
11. Picard, F.; Kurlev, M.; Chung, N.; Topark-Ngarm, A.; Senawong, T.; Machado de Oliveira, R.; Leid, M.; McBurney, M. W.; Guarante, L. Sirt1 promotes fat mobilization in white adipocytes by repressing PPAR-gamma Nature 2004, 429, 771-776
12. Floyd, Z. E.; Wang, Z. Q.; Kilroy, G.; Cefalu, W. T. Modulation of peroxisome proliferator-activated receptor gamma stability and transcriptional activity in adipocytes by resveratrol Metabolism 2008, 57 (Suppl. 1) S32-S38
13. Bai, L.; Pang, W. J.; Yang, Y. J.; Yang, G. S. Modulation of Sirt1 by resveratrol and nicotinamide alters proliferation and differentiation for pig adipocytes Mol. Cell. Biochem. 2008, 307, 129-140
14. Rayalam, S.; Yang, J. Y.; Ambati, S.; Della-Ferra, M. A.; Baile, C. A. Resveratrol induces apoptosis and inhibits adipogenesis in 3T3-L1 adipocytes Phytother. Res. 2008, 22, 1367-1371
15. Azorín-Ortuño, M.; Yañéz-Gascón, M. J.; Pallarés, F. J.; Vallejo, F.; Larrosa, M.; García-Conesa, M. T.; Tomás-Barberán, F.; Espín, J. C. Pharmacokinetic study of trans -resveratrol in adult pigs J. Agric. Food Chem. 2010, 58, 11165-11171
16. Crowell, J. A.; Korytko, P. J.; Morrissey, R. L.; Booth, T. D.; Levine, B. S. Resveratrol-associated renal toxicity Toxicol. Sci. 2004, 82, 614-619
17. Brown, V. A.; Patel, K. R.; Viskaduraki, M.; Crowell, J. A.; Perloff, M.; Booth, T. D.; Vasilinin, G.; Sen, A.; Schinas, A. M.; Piccirilli, G.; Brown, K.; Steward, W. P.; Gescher, A. J.; Brenner, D. E. Repeat dose study of the cancer chemopreventive agent resveratrol in healthy volunteers: Safety, pharmacokinetics, and effect on the insulin-like growth factor axis Cancer Res. 2010, 70, 9003-9011
18. Hoshino, J.; Park, E. J.; Kondratyuk, T. P.; Marler, L.; Pezzuto, J. M.; van Breemen, R. B.; Mo, S.; Li, Y.; Cushman, M. Selective synthesis and biological evaluation of sulfate-conjugated resveratrol metabolites J. Med. Chem. 2010, 53, 5033-5043
19. Delmas, D.; Aires, V.; Limagne, E.; Dutartre, P.; Mazué, F.; Ghiringhelli, F.; Latruffe, N. Transport, stability, and biological activity of resveratrol Ann. N.Y. Acad. Sci. 2011, 1215, 48-59
20. Chachay, V. S.; Kirkpatrick, C. M.; Hickman, I. J.; Ferguson, M.; Prins, J. B.; Martin, J. H. Resveratrol-Pills to replace a healthy diet? Br. J. Clin. Pharmacol. 2011, 72, 27-38
21. Macarulla, M. T.; Alberdi, G.; Gómez, S.; Tueros, I.; Bald, C.; Rodríguez, V. M.; Martínez, J. A.; Portillo, M. P. Effects of different doses of resveratrol on body fat and serum parameters in rats fed a hypecaloric diet J. Physiol. Biochem. 2009, 65, 369-376
22. Reagan-Shaw, S.; Nihal, M.; Ahmad, N. Dose translation from animal to human studies revisited FASEB J. 2007, 22, 659-661
23. Miksits, M.; Maier-Salamon, A.; Aust, S.; Thalhammer, T.; Reznicek, G.; Kunert, O.; Haslinger, E.; Szekeres, T.; Jaeger, W. Sulfation of resveratrol in human liver: Evidence of a major role for the sulfotransferases SULT1A1 and SULT1E1 Xenobiotica 2005, 35, 1101-1119
24. Thakkar, K.; Geahlen, R. L.; Cushman, M. Synthesis and protein-tyrosine kinase inhibitory activity of polyhydroxylated stilbene analogues of piceatannol J. Med. Chem. 1993, 36, 2950-2955
25. Malz, F.; Jancke, H. Validation of quantitative NMR J. Pharm. Biomed. Anal. 2005, 38, 813-823
26. Urpí-Sardà, M.; Zamora-Ros, R.; Lamuela-Raventós, R.; Cherubini, A.; Jáuregui, O.; de la Torre, R.; Covas, M. I.; Estruch, R.; Jaeger, W.; Andrés-Lacueva, C. HPLC-tandem mass spectrometric method to characterize resveratrol metabolism in humans Clin. Chem. 2007, 53, 292-299
27. Andrés-Lacueva, C.; Shukitt-Hale, B.; Galli, R. L.; Jauregui, O.; Lamuela-Raventos, R.; Joseph, J. A. Anthocyanins in aged blueberry-fed rats are found centrally and may enhance memory Nutr. Neurosci. 2005, 8, 111-120
28. US Department of Health and Human Services, Food and Drug Administration. Guidance for Industry Bioanalytical Method Validation. 2001; http://www.fda.gov/cder/guidance/4252fnl.htm
29. Wang, L. X.; Heredia, A.; Song, H.; Zhang, Z.; Yu, B.; Davis, C.; Redfield, R. Resveratrol glucuronides as the metabolites of resveratrol in humans: Characterization, synthesis, and anti-HIV activity J. Pharm. Sci. 2004, 93, 2448-2457
30. Szkudelska, K.; Szkudelski, T. Resveratrol, obesity and diabetes Eur. J. Pharmacol. 2010, 635, 1-8
31. Lagouge, M.; Argmann, C.; Gerhart-Hines, Z.; Meziane, H.; Lerin, C.; Daussin, F.; Messadeq, N.; Milne, J.; Lambert, P.; Elliott, P.; Geny, B.; Laakso, M.; Puigserver, P.; Auwerx, J. Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alpha Cell 2006, 127, 1109-1122
32. Baur, J. A.; Pearson, K. J.; Price, N. L.; Jamieson, H. A.; Lerin, C.; Kalra, A.; Prabhu, V. V.; Allard, J. S.; Lopez-Lluch, G.; Lewis, K.; Pistell, P. J.; Poosala, S.; Becker, K. G.; Boss, O.; Gwinn, D.; Wang, M.; Ramaswamy, S.; Fishbein, K. W.; Spencer, R. G.; Lakatta., E. G.; Le Couteur, D.; Shaw, R. J.; Navas, P.; Puigserver, P.; Ingram, D. K.; de Cabo, R.; Sinclair, D. A. Resveratrol improves health and survival of mice on a high-calorie diet Nature 2006, 444, 337-342
33. Patel, K. R.; Scott, E.; Brown, V. A.; Gescher, A. J.; Steward, W. P.; Brown, K. Clinical trials of resveratrol Ann. N.Y. Acad. Sci. 2011, 1215, 161-169
34. Juan, M. E.; Maijó, M.; Planas, J. M. Quantification of trans -resveratrol and its metabolites in rat plasma and tissues by HPLC J. Pharm. Biomed. Anal. 2010, 51, 391-398
35. Vaz-da-Silva, M.; Loureiro, A. I.; Falcao, A.; Nunes, T.; Rocha, J. F.; Fernandes-Lopes, C.; Soares, E.; Wright, L.; Almeida, L.; Soares-da-Silva, P. Effect of food on pharmakokinetics profile of trans -resveratrol Int. J. Clin. Pharmacol. Ther. 2008, 46, 564-570
36. La Porte, C.; Voduc, N.; Zhang, G.; Seguin, I.; Tardiff, D.; Singhal, N.; Cameron, D. W. Steady-state pharmacokinetics and tolerability of trans -resveratrol 2000 mg twice daily with food, quercetin and alcohol (ethanol) in healthy human subjects Clin. Pharmacokinet. 2010, 49, 449-454
37. Yu, C.; Shin, Y. G.; Chow, A.; Li, Y.; Kosmeder, J. W.; Lee, Y. S.; Hirschelman, W. H.; Pezzuto, J. M.; Mehta, R. G.; van Breemen, R. B. Human, rat and mouse metabolism of resveratrol Pharm. Res. 2002, 19, 1907-1914
38. 14C]- trans -resveratrol, a cancer chemopreventive polyphenol, in mouse tissues after oral administration Life Sci. 2003, 72, 2219-2233
39. Sale, S.; Verschoyle, R. D.; Boocock, D.; Jones, D. J.; Wilsher, N.; Ruparelia, K. C.; Potter, G. A.; Farmer, P. B.; Steward, W. P.; Gescher, A. J. Pharmacokinetics in mice and growth-inhibitory properties of the putative cancer chemopreventive agent resveratrol and the synthetic analogue trans -3,4,5,4′-tetramethoxystilbene Br. J. Cancer 2004, 90, 736-744
40. Azorín-Ortuño, M.; Yáñez-Gascón, M. J.; Vallejo, F.; Pallarés, F. J.; Larrosa, M.; Lucas, R.; Morales, J. C.; Tomás-Barberán, F. A.; García-Conesa, M. T.; Espín, J. C. Metabolites and tissue distribution of resveratrol in the pig Mol. Nutr. Food Res. 2011, 55, 1154-1168
41. Rivera, L.; Morón, R.; Zarzuelo, A.; Galisteo, M. Long-term resveratrol administration reduces metabolic disturbances and lowers blood pressure in obese Zucker rats Biochem. Pharmacol. 2009, 77, 1053-1063
42. Baile, C. A.; Yang, J. Y.; Rayalam, S.; Hartzell, D. L.; Lai, C. Y.; Andersen, C.; Della-Fera, M. A. Effect of resveratrol on fat mobilization Ann. N.Y. Acad. Sci. 2011, 1215, 40-47
43. Alberdi, G.; Rodríguez, V. M.; Miranda, J.; Macarulla, M. T.; Arias, N.; Andrés-Lacueva, C.; Portillo, M. P. Changes in white adipose tissue metabolism induced by resveratrol in rats Nutr. Metab. 2011, 8, 29
44. Zamora-Ros, R.; Urpí-Sardà, M.; Lamuela-Raventós, R. M.; Estruch, R.; Martínez-González, M. A.; Bulló, M.; Arós, F.; Cherubini, A.; Andres-Lacueva, C. Resveratrol metabolites in urine as a biomarker of wine intake in free-living subjects: The PREDIMED Study Free Radical Biol. Med. 2009, 46, 1562-1566
45. Weinbrenner, T.; Fitó, M.; de la Torre, R.; Saez, G. T.; Rijken, P.; Tormos, C.; Coolen, S.; Albaladejo, M. F.; Abanades, S.; Schroder, H.; Marrugat, J.; Covas, M. I. Olive oils high in phenolic compounds modulate oxidative/antioxidative status in men J. Nutr. 2004, 134, 2314-2321
46. Wang, D.; Hang, T.; Wu, C.; Liu, W. Identification of the major metabolites of resveratrol in rat urine by HPLC-MS/MS J. Chromatogr. B Anal. Technol. Biomed. Life Sci. 2005, 829, 97-106
47. Kapetanovic, I. M.; Muzzio, M.; Huang, Z.; Thompson, T. N.; McCormick, D. L. Pharmacokinetics, oral bioavailability, and metabolic profile of resveratrol and its dimethylether analog, pterostilbene, in rats Cancer Chemother. Pharmacol. 2011, 68, 593-601
48. Maier-Salamon, A.; Hagenauer, B.; Wirth, M.; Gabor, F.; Szekeres, T.; Jäger, W. Increased transport of resveratrol across monolayers of the human intestinal Caco-2 cells is mediated by inhibition and saturation of metabolites Pharm. Res. 2006, 23, 2107-2115